Modulating Immunity in Ischemic Injury
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : University of Virginia Health System
Protocol cited in 1 other protocol
Variable analysis
- Isotype control antibodies
- Blocking antibodies (anti-PD-L1, anti-PD-L2)
- Not explicitly mentioned
- Mice (WT)
- Timing of antibody administration (24 hours prior to IRI)
- Timing of Treg administration (18 hours prior to IRI, 6 hours after antibody injection)
- Treg isolation protocol (Dynal CD4 negative selection, Miltenyi Biotec CD25 positive selection)
- Positive control: Rat IgG2a (clone: 2A3) for anti-PD-L2
- Positive control: Rat IgG2b (clone: LTF-2) for anti-PD-L1
- Negative control: Untreated/saline-treated group not mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!